AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...
Zacks.com on MSN
Dynatrace (DT) Stock Sinks As Market Gains: What You Should Know
Dynatrace (DT) reached $43.74 at the closing of the latest trading day, reflecting a -1.93% change compared to its last close.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback